Recalls / Class III
Class IIID-1246-2014
Product
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
- Brand name
- Nicorette
- Generic name
- Nicotine Polacrilex
- Active ingredient
- Nicotine
- Route
- Oral
- NDCs
- 0135-0508, 0135-0509
- FDA application
- NDA022360
- Affected lot / code info
- (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)
Why it was recalled
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Recalling firm
- Firm
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
- Manufacturer
- Haleon US Holdings LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 65 Windham Blvd, N/A, Aiken, South Carolina 29805-9384
Distribution
- Quantity
- 189,900 20 ct Vials, 145,068 81 ct Vials
- Distribution pattern
- U.S. Nationwide
Timeline
- Recall initiated
- 2014-02-20
- FDA classified
- 2014-04-18
- Posted by FDA
- 2014-04-30
- Terminated
- 2017-01-20
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1246-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.